Effect of HI-6, Applied into the Cerebral Ventricles, on the Inhibition of Brain Acetylcholinesterase by Soman in Rats
Overview
Pharmacology
Affiliations
When applied to rats (intraperitoneally) immediately after subcutaneous injection of soman (120 micrograms/kg) HI-6 (100 mg/kg) protected about 40% of the activity of acetylcholinesterase (AChE) in the motor end plate region of the diaphragm but did not protect AChE in the brain. However, a partial protection of AChE in brain against inhibition by soman was obtained in anaesthetized, atropinized rats by the oxime injected into the cerebral ventricle 5 min before parenteral exposure to soman. The AChE activity in brain of rats pretreated with HI-6, analyzed 60 min after the injection of soman was between 10 and 19%, while that in non-protected animals did not exceed 1% of the control. The degree of protection of AChE in brain was dose-dependent. Large doses of HI-6 (greater than or equal to 100 micrograms) were tolerated by animals because of the pentobarbital anaesthesia which counteracted the lethal action of HI-6. The rate of "aging" of AChE in brain inhibited by soman was analyzed by intracerebroventricular injection of 200 micrograms of HI-6 at different time intervals after the subcutaneous injection of soman. A statistically-significant reactivation of inhibited AChE activity in brain was demonstrated when HI-6 was applied up to 20 min after soman. The protection and reactivation by HI-6 of both AChE in brain and AChE in muscle end plates in poisoning with soman appear to be quite similar.
Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.
Klimmek R, Eyer P Arch Toxicol. 1986; 59(4):272-8.
PMID: 3827595 DOI: 10.1007/BF00290550.
Studies on the decomposition of the oxime HI 6 in aqueous solution.
Eyer P, Hell W, Kawan A, KLEHR H Arch Toxicol. 1986; 59(4):266-71.
PMID: 3827594 DOI: 10.1007/BF00290549.
Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.
Eyer P, Ladstetter B, Schafer W, SONNENBICHLER J Arch Toxicol. 1989; 63(1):59-67.
PMID: 2742503 DOI: 10.1007/BF00334636.
DEKLEVA A, Sket D, Sketelj J, Brzin M Acta Neuropathol. 1989; 79(2):183-9.
PMID: 2596267 DOI: 10.1007/BF00294377.